Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President, CEO, Director

SVP, Chief Operations Officer

EVP, CFO, Treasurer

EVP, General Counsel, Corp Sec

EVP, Human Resources

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and bone preserving joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief; and Hyvisc, a molecular weight injectable HA veterinary product. The company's joint preservation and restoration product family comprises 150 bone preserving joint technology products, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and orthopedic regenerative solutions, including Hyalofast and Tactoset. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including adhesion barrier, advanced wound care, ear, nose, and throat products, as well as ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the are...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-11	Premium	acquired	Premium	Premium	Premium	President, CEO, Director
2024-03-11	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Operations Officer
2024-03-11	Premium	acquired	Premium	Premium	Premium	SVP, Chief Operations Officer
2024-03-11	Premium	acquired	Premium	Premium	Premium	EVP, CFO, Treasurer
2024-03-11	Premium	acquired	Premium	Premium	Premium	EVP, General Counsel, Corp Sec
2024-03-11	Premium	sold (taxes)	Premium	Premium	Premium	EVP, CFO, Treasurer
2024-03-11	Premium	sold (taxes)	Premium	Premium	Premium	EVP, General Counsel, Corp Sec
2024-03-11	Premium	sold (taxes)	Premium	Premium	Premium	President, CEO, Director
2023-10-01	Premium	acquired	Premium	Premium	Premium	SVP, Chief Operations Officer
2023-10-01	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Chief Operations Officer
2023-08-10	Premium	acquired	Premium	Premium	Premium	EVP, CFO, Treasurer
2023-08-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, CFO, Treasurer
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-06-14	Premium	acquired	Premium	Premium	Premium	-
2023-04-26	Premium	sold (taxes)	Premium	Premium	Premium	President, CEO, Director
2023-04-26	Premium	acquired	Premium	Premium	Premium	President, CEO, Director
2023-04-13	Premium	acquired	Premium	Premium	Premium	-
2023-03-10	Premium	acquired	Premium	Premium	Premium	EVP, CFO, Treasurer
2023-03-10	Premium	sold (taxes)	Premium	Premium	Premium	EVP, CFO, Treasurer
2023-03-10	Premium	acquired	Premium	Premium	Premium	President, CEO, Director

ANIK - Anika Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ANIK